COREY CHEUNG
PHARMACEUTICALS innovative and reliable as the products our customers create – ensuring that patients everywhere receive the right treatment, at the right time, with complete confidence.”
Creating a unified global healthcare logistics brand To reflect its expanding role in this sector, DHL is bringing all of its life sciences and healthcare services together under one name: DHL Health Logistics.
It is not just about moving goods. DHL wants to streamline how customers interact with its systems, offering integrated services across countries and sectors to reduce friction, lower costs and speed up delivery.
The company’ s current network includes nearly 600 sites across close to 130 countries, with more than 2.5 million square metres of temperaturecontrolled space already in operation.
The investment will build on this footprint, allowing for more scalability and resilience as demand rises.
A strategic play with patient care at its core Behind this expansion is a commercial opportunity. DHL’ s life sciences and healthcare logistics generated more than US $ 5.4bn in revenue in 2024 and the group is projecting another US $ 5.4bn in incremental revenue by 2030.
It is a strong growth sector, fuelled by the increasing global demand for personalised medicine, clinical trials and specialised treatments.
Alongside the growth outlook, DHL is positioning itself as a company with a broader mission – one that connects logistics with real-world patient outcomes.
COREY CHEUNG
TITLE: VP OF BUSINESS DEVELOPMENT FOR ASIA-PACIFIC
COMPANY: UPS HEALTHCARE INDUSTRY: HEALTHCARE LOGISTICS LOCATION: HONG KONG
healthcare-digital. com 117